Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Genetic Research » Telomere Length Linked to Genomic Alterations in 31 Cancers

Telomere Length Linked to Genomic Alterations in 31 Cancers

Jan 30, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Cancer cells use a variety of mechanisms to survive cellular crisis, including through telomere maintenance processes. By activating telomerase, cancer cells can counteract telomere shortening, and therefore avoid tumor-suppressing senescence and crisis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
02
Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Cancer

  1. European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

    Premium

  2. Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx

    Premium

  3. Tempus Gets CE Mark for xT Tumor Sequencing Assay

  4. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

  5. Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.